Vaccines

Search

Search

Vaccination, probably the most controversial word on the planet!

“Untruth naturally afflicts historical information.

There are various reasons that make this unavoidable. One of them is partisanship for opinions and schools. If the soul is impartial in receiving information, it devotes to that information the share of critical investigation the information deserves, and its truth or untruth thus becomes clear.

However, if the soul is infected with partisanship for a particular opinion or sect, it accepts without a moment’s hesitation the information that is agreeable to it. Prejudice and partisanship obscure the critical faculty and preclude critical investigation.

The result is that falsehoods are accepted and transmitted” 

(Muhammad ibn Khaldun al-Hadrami 1379, 1–2Muhammad ibn Khaldun al-Hadrami, Abu Zayd ’Abd ar-Rahman ibn. 1379. Muqaddimat Ibn Khaldun Li-Kitab Al-’ibar Wa-Diwan Al-Mubtada’ Wa-Al-Khabar Fi Ayyam Al-’Arab Wa-Al-’Ajam Wa-Al-Barbar, Wa-Man ’asarahum Min Dhawi Al-Sultan Al-Akbar. Misr : al-Mataba’ah al-Bahiyah al-Misriyah. http://archive.org/details/McGillLibrary-rbsc_isl_kitab-al-ibar_muqaddimah_d167l2361900z-16098.).

---

I have never been critical against any vaccine whatsoever; have had all my vaccinations in the 60’s, some more serving the Dutch navy (1978) and in 2010 another 3 shots due to business travel.

Rushing a vaccine with a technology never registered anywhere in the world before; for a virus with a global iFR 0.15-0.20% (0.03-0.04% in those <70 years) [source John P. A. Ioannidis] to me is utterly madness.

Anyone with a healthy brain should think beyond general statements broadcasted by the main stream media, be critical, questioning the information and do his/her own research.

---

‘The WHO recommendations for vaccines are a one-size fits all and this fact means that these policies will increase diseases in all populations.

They cannot be described as ‘protective health policies’ because they contradict the science of epigenetics; the science showing that individuals are pre-disposed to diseases due to their genetic make-up and the interaction with chemicals in the vaccines.

–Judy Wilyman PhD

Translate this blog in Deutsch Italiano Portoghese Española Ελληνικά or any other language

Pandemic Strategies: Lessons and Consequences – International Conference in Stockholm

Jan 21, 2023
Our international conference at the Stockholm Waterfront 21-22 January 2023.
15 leading doctors, researchers and lawyers from the US, Canada, UK, Germany, France, Belgium, Switzerland, Israel, Ukraine and Norway, along with 7 Swedes.

An independent production company was on site to record all angles of the conference and to provide them to the public via this page. Make sure to check back regularly, as we publishing further presentations and interviews over the coming days.

Presentations and panel discussions (3 per day) will be released in the order that they appeared on the program. Interviews and other content to follow shortly…….stay tuned!

https://lakaruppropet.se/international-conference-pandemic-strategies/

Will covid-19 vaccines save lives? Current trials aren’t designed to tell us

The world has bet the farm on vaccines as the solution to the pandemic, but the trials are not focused on answering the questions many might assume they are. Peter Doshi reports

As phase III trials of covid-19 vaccines reach their target enrolments, officials have been trying to project calm. The US coronavirus czar Anthony Fauci and the Food and Drug Administration leadership have offered public assurances that established procedures will be followed. Only a “safe and effective” vaccine will be approved, they say, and nine vaccine manufacturers issued a rare joint statement pledging not to prematurely seek regulatory review.

But what will it mean exactly when a vaccine is declared “effective”? To the public this seems fairly obvious. “The primary goal of a covid-19 vaccine is to keep people from getting very sick and dying,” a National Public Radio broadcast said bluntly.

Peter Hotez, dean of the National School of Tropical Medicine at Baylor College of Medicine in Houston, said, “Ideally, you want an antiviral vaccine to do two things first, reduce the likelihood you will get severely ill and go to the hospital, and two, prevent infection and therefore interrupt disease transmission.”

Yet the current phase III trials are not actually set up to prove either. None of the trials currently under way are designed to detect a reduction in any serious outcome such as hospital admissions, use of intensive care, or deaths. Nor are the vaccines being studied to determine whether they can interrupt transmission of the virus. https://www.bmj.com/content/371/bmj.m4037

The Safety of COVID-19 Vaccinations

REACT19 – Scientific Publications Directory

Collection of peer reviewed case reports and studies citing adverse effects post COVID vaccination.

Researching Covid vaccine adverse events can be daunting in part due to a broad myriad of factors. Primarily, the information is incredibly challenging to find. Here, we share an ever growing list of peer-reviewed studies specific to Covid vaccine adverse events. This list is curated and maintained by our dedicated staff of injured PhDs and medical professionals.

Before diving in, please take a look at our Research Primer: How to Read and Understand Research for tools to how best approach the massive amount of information found in the document below. As always, this is for informational purposes only. Please discuss with your trusted medical team.

December 22, 2023 – 3,580 entries https://react19.org/science

Round Table Discussion on COVID Vaccines

On Wednesday December 7 2022, Senator Ron Johnson (R-WI) hosted a roundtable discussion 

“COVID-19 Vaccines: What They Are, How They Work, and Possible Causes of Injuries” to expose the dangers of the experimental mRNA Covid vaccine.

Peter McCullough, Robert Malone, Ryan Cole, Pierre Kory, Paul Marik, Harvey Risch, Aaron Siri, Esq. (ICAN’s attorney), Edward Dowd, OpenVAERS’ founder, Liz Willner, David Gortler, and others.

COVID-19 mRNA Vaccines: Lessons Learned from the Registrational Trials and Global Vaccination Campaign

Published: January 24, 2024
Mead M, Seneff S, Wolfinger R, et al. (January 24, 2024) COVID-19 mRNA Vaccines: Lessons Learned from the Registrational Trials and Global Vaccination Campaign. Cureus 16(1): e52876. doi:10.7759/cureus.52876

Abstract
Our understanding of COVID-19 vaccinations and their impact on health and mortality has evolved substantially since the first vaccine rollouts. Published reports from the original randomized phase 3 trials concluded that the COVID-19 mRNA vaccines could greatly reduce COVID-19 symptoms. In the interim, problems with the methods, execution, and reporting of these pivotal trials have emerged. Re-analysis of the Pfizer trial data identified statistically significant increases in serious adverse events (SAEs) in the vaccine group. Numerous SAEs were identified following the Emergency Use Authorization (EUA), including death, cancer, cardiac events, and various autoimmune, hematological, reproductive, and neurological disorders. Furthermore, these products never underwent adequate safety and toxicological testing in accordance with previously established scientific standards. Among the other major topics addressed in this narrative review are the published analyses of serious harms to humans, quality control issues and process-related impurities, mechanisms underlying adverse events (AEs), the immunologic basis for vaccine inefficacy, and concerning mortality trends based on the registrational trial data. The risk-benefit imbalance substantiated by the evidence to date contraindicates further booster injections and suggests that, at a minimum, the mRNA injections should be removed from the childhood immunization program until proper safety and toxicological studies are conducted. Federal agency approval of the COVID-19 mRNA vaccines on a blanket-coverage population-wide basis had no support from an honest assessment of all relevant registrational data and commensurate consideration of risks versus benefits. Given the extensive, well-documented SAEs and unacceptably high harm-to-reward ratio, we urge governments to endorse a global moratorium on the modified mRNA products until all relevant questions pertaining to causality, residual DNA, and aberrant protein production are answered.

Conclusions (page 25)
Careful, objective evaluation of COVID-19 mRNA product safety is crucial for upholding ethical standards and evidence-informed decision-making. Our narrative review concerning the registrational trials and the EUA’s aftermath offers evidence-informed insights into how these genetic vaccines were able to enter the market. In the context of the two pivotal trials, safety was never assessed in a manner commensurate with previously established scientific standards either for vaccines or for GTPs, the more accurate classification ofthese products. Many key trial findings were either misreported or omitted entirely from published reports.

The usual safety testing protocols and toxicology requirements were bypassed by the FDA and vaccine manufacturers, and the premature termination of both trials obviated any unbiased assessment of potential SAEs due to an insufficient timeframe for proper trial evaluation. It was only after the EUA that the serious biological consequences of rushing the trials became evident, with numerous cardiovascular, neurological, reproductive, hematological, malignant, and autoimmune SAEs identified and published in the peer reviewedmedical literature.

Moreover, the COVID-19 mRNA vaccines produced via Process 1 and evaluated in the trials were not the same products eventually distributed worldwide; all of the COVID-19 mRNA products released to the public were produced via Process 2 and have been shown to have varying degrees of DNA contamination.

The failure of regulatory authorities to heretofore disclose process-related impurities (e.g., SV40) has further increased concerns regarding safety and quality control oversight of mRNA vaccine manufacturing processes.

Since early 2021, excess deaths, cardiac events, strokes, and other SAEs have often been wrongly ascribed to COVID-19 rather than to the COVID-19 mRNA vaccinations. Misattribution of SAEs to COVID-19 often may be due to the amplification of adverse effects when mRNA injections are followed by SARS-CoV-2 subvariant infection. Injuries from the mRNA products overlap with both PACS and severe acute COVID-19 illness, often obscuring the vaccines’ etiologic contributions. Multiple booster injections appear to cause immune dysfunction, thereby paradoxically contributing to heightened susceptibility to COVID-19 infections with successive doses. For the vast majority of adults under the age of 50, the perceived benefits of the mRNA boosters are profoundly outweighed by their potential disabling and life-threatening harms. Potential harms to older adults appear to be excessive as well. Given the well-documented SAEs and unacceptable harm-torewardratio, we urge governments to endorse and enforce a global moratorium on these modified mRNA products until all relevant questions pertaining to causality, residual DNA, and aberrant protein production are answered.
https://www.cureus.com/articles/203052-covid-19-mrna-vaccines-lessons-learned-from-the-registrational-trials-and-global-vaccination-campaign#!/

References: Page 28-38

Presence of viral spike protein and vaccinal spike protein in the blood serum of patients with long-COVID syndrome

Abstract. – OBJECTIVE: COVID-19 patients experience, in 10-20% of the cases, a prolonged long-COVID syndrome, defined as the persistence of symptoms for at least two months after the infection.

The underlying biological mechanisms of this syndrome remain poorly understood. Several hypotheses have been proposed, among which are the potential autoimmunity resulting from molecular mimicry between viral spike protein and human proteins, the reservoir and viral reproduction hypothesis, and the viral integration hypothesis.

Although official data state that vaccinal spike protein is harmless and remains at the site of infection, several studies proposed spike protein toxicity and found it in blood circulation several months after the vaccination. https://www.europeanreview.org/article/34685

Vaccines Against COVID-19 Worse Than the Disease? Reviewing Some Possible Unintended Consequences of the mRNA

Experimental mRNA vaccines have been heralded as having the potential for great benefits, but they also harbor the possibility of potentially tragic and even catastrophic unforeseen consequences.
The mRNA vaccines against SARS-CoV-2 have been implemented with great fanfare, but there are many aspects of their widespread utilization that merit concern.
We have reviewed some, but not all, of those concerns here, and we want to emphasize that these concerns are potentially serious and might not be evident for years or even transgenerationally.
In order to adequately rule out the adverse potentialities described in this paper, we recommend, at a minimum, that the following research and surveillance practices be adopted:

A national effort to collect detailed data on adverse events associated with the mRNA vaccines with abundant funding allocation, tracked well beyond the first couple of weeks after vaccination.

Repeated autoantibody testing of the vaccine-recipient population. The autoantibodies tested could be standardized and should be based upon previously documented antibodies and autoantibodies potentially elicited by the spike protein. These include autoantibodies against phospholipids, collagen, actin, thyroperoxidase (TPO), myelin basic protein, tissue transglutaminase, and perhaps others.

Immunological profiling related to cytokine balance and related biological effects. Tests should include, at a minimum, IL-6, INF-α, D-dimer, fibrinogen, and C-reactive protein.

Studies comparing populations who were vaccinated with the mRNA vaccines and those who were not to confirm the expected decreased infection rate and milder symptoms of the vaccinated group, whileat the same time comparing the rates of various autoimmune diseases and prion diseases in the same two populations.

Studies to assess whether it is possible for an unvaccinated person to acquire vaccine-specific forms of the spike proteins from a vaccinated person in close proximity.

In vitro studies to assess whether the mRNA nanoparticles can be taken up by sperm and converted into cDNA plasmids.

Animal studies to determine whether vaccination shortly before conception can result in offspring carrying spike-protein-encoding plasmids in their tissues, possibly integrated into their genome.

In vitro studies aimed to better understand the toxicity of the spike protein to the brain, heart, testes, etc. https://ijvtpr.com/index.php/IJVTPR/article/view/23/51

VAERS Analysis Weekly analysis of the VAERS data

I am just a concerned citizen reporting on often overlooked public data regarding adverse events related to the new Covid-19 vaccines. I work with data for a living and have been in the technology field for over two decades.
https://vaersanalysis.info/about/

Official DEATH Signal for Covid-19 jabs was present in VAERS just 1 month after rollout

Quick Summary:

The CDC has been extremely negligent in following its own protocols as far as safety signal analysis for the Covid-19 shots. Their protocols state that they will perform a safety signal analysis on a weekly basis, using something called the Proportional Reporting Ratio (PRR).

As far as anyone knows (and only because of FOIA requests by independent investigators), the CDC had not done the PRR safety signal analysis for the Covid-19 shots prior to March of 2022, which was a full 15 months after the initial rollout. Obviously, you did not hear about any of this, because the CDC didn’t do the safety analysis (or suppressed it).

The CDC VAERS data for death events for the Covid-19 shots triggered a safety signal for DEATH as early as 1/15/2021, just a month or so after the initial rollout. (At that point in time, there were 181 documented deaths in association with the Covid-19 shots.) Obviously, you did not hear about any of this, because the CDC didn’t do the safety analysis (or suppressed it).

If the data is age-stratified, the DEATH safety signal was triggered even earlier; as early as 12/30/2020 for 80+ year olds, and as early as 1/8/2021 for the 60-64, 65-79 year olds. Once again, you did not hear about this, because the CDC didn’t do the safety analysis (or suppressed it).

At a minimum, a further investigation should take place to determine exactly when safety signals were first generated for each of the major symptoms of special interest as identified in their published standard operating procedure (if not for all symptoms).

It is reasonable to conclude that the CDC has been found shockingly derelict in its duty and role to protect public health, and as such it should be obvious that the CDC should be defunded and dismantled immediately and responsible parties brought to justice.

Steve Kirsch’s newsletter

https://stevekirsch.substack.com/

An open letter to CDC director Walensky: Why have you ignored the DEATH safety signal in VAERS for more than 2 years?

I tried billboards to get their answer, but now it’s time to ramp up the campaign. Here’s my email to the CDC director.

Thanks to the brilliant work of VAERS Analysis, we now know that the DEATH safety signal was first triggered in VAERS less than a month after the vaccines rolled out. Nobody at the CDC cared enough to alert the public that a killer vaccine had been unleashed.

Members of Congress are not calling for an investigation. They are doing nothing. Not even a letter to Walensky to ask what’s up.

The mainstream media is doing nothing as usual. No stories. No investigation. The CDC can ignore hundreds of safety signals and that’s just perfectly OK with the media.

So it is clearly my personal responsibility to inform the American people directly that hundreds of safety signals (including death) triggered in VAERS and not only does the CDC know it (we know that from the FOIA requests), but they are doing absolutely nothing to inform the public.

https://stevekirsch.substack.com/p/the-cdc-has-been-ignoring-the-death?utm_source=twitter&utm_campaign=auto_share&r=o7iqo

Pfizer trials more people died in the vaccinated group

In Pfizer’s own trials more people died in the vaccinated group than the placebo group. And now we wonder why highly vaccinated nations have ‘unexplainable’ excess mortality.

SARS-CoV-2 spike mRNA vaccine sequences circulate in blood 

First published: 17 January 2023
Full-length or traces of SARS-CoV-2 spike mRNA vaccine sequences were found in blood up to 28 days after COVID-19 vaccination.

https://pubmed.ncbi.nlm.nih.gov/36647776/

Abstract
In Denmark, vaccination against Severe Acute Respiratory Syndrome Corona Virus 2 (SARS-CoV-2) has been with the Pfizer-BioNTech (BTN162b2) or the Moderna (mRNA-1273) mRNA vaccines.

Patients with chronic hepatitis C virus (HCV) infection followed in our clinic received mRNA vaccinations according to the Danish roll-out vaccination plan.

To monitor HCV infection, RNA was extracted from patient plasma and RNA sequencing was performed on the Illumina platform. In 10 of 108 HCV patient samples, full-length or traces of SARS-CoV-2 spike mRNA vaccine sequences were found in blood up to 28 days after COVID-19 vaccination.

Detection of mRNA vaccine sequences in blood after vaccination adds important knowledge regarding this technology and should lead to further research into the design of lipid-nanoparticles and the half-life of these and mRNA vaccines in humans.

https://onlinelibrary.wiley.com/doi/epdf/10.1111/apm.13294

Covid-19 vaccine boosters for young adults: A risk-benefit assessment 

‘Unethical’ and up to 98 Times Worse Than the Disease: Top Scientists Publish Paradigm-Shifting Study About COVID-19 Vaccines.
BY JENNIFER MARGULIS AND JOE WANG – SEPTEMBER 10, 202

Study:

Nanotechnology: self assembly structures in mRNA-injections

In this episode of ICIC, Dr Reiner Fuellmich and co-host Dr Mike Yeadon have an insightful conversation with four experts on this explosive topic.

Using dark-field microscopy, Dr David Nixon examines blood samples from people who have been injected with mRNA-based substances and explains the results with corresponding images. Crystalline, unnatural structures are revealed, which change in further observation and show characteristics of a kind of nano- or micro-technology.

Dr. Ana Maria Mihalcea is intensively involved with the ingredients of the Covid mRNA substances. In particular, also with the so-called “shedding effect” of which it is assumed that harmful excretions can be transferred from “vaccinated” to “unvaccinated”.

Karen Kingston, whose research interests include toxicology and the analysis of clinical data as well as the ingredients of the covid mRNA substances, complains that all measures regarding a functioning quality assurance management in the administration of a so-called novel “vaccination” to billions of people worldwide have failed and are still not being implemented after the already poor data situation.

For electrical engineer Shimon Yanowitz, the results of his research have shown that it is a kind of micro-technology, as the injected substances change strangely in the human body and have characteristics of electronic circuits. It is also disturbing that the lipid nanoparticles found in the substances have been approved as “technical devices”, as Karen Kingston reports.
https://video.icic-net.com/w/d45c3f4a-7e9b-4478-be6f-820269343c85

Microscopic Analysis on the Blood After Pfizer/BioNtech or Moderna

The use of dark field microscopic analysis of fresh peripheral blood on a slide was once widespread in medicine, allowing a first and immediate assessment of the state of health of the corpuscular components of the blood.

In the present study we analyzed with a dark field optical microscope the peripheral blood drop from 1006 symptomatic subjects after inoculation with an mRNA injection (Pfizer/BioNTech or Moderna), starting from March 2021.

There were 948 subjects (94% of the total sample ) whose blood showed aggregation of erythrocytes and the presence of particles of various shapes and sizes of unclear origin one month after the mRNA inoculation.
In 12 subjects blood was examined with the same method before vaccination, showing a perfectly normal hematological distribution.

The alterations found after the inoculation of the mRNA injections further reinforce the suspicion that the modifications were due to the so called “ vaccines themselves.

We report 4 clinical cases, chosen as representative of the entire case series. Further studies are needed to define the exact nature of the particles found in the blood and to identify possible solutions to the problems they are evidently causing.

Of the 1006 cases analyzed, only 58 (27 males and 31 females), equal to 5.77% of the total, presented a completely normal hematological picture upon microscopic analysis after the last mRNA injection with either the Moderna or Pfizer concoction. The vaccines are purported to contain at least the spike protein from SARS-CoV-2 (Nance &Meier, 2021), but is known also to contain foreign particles that the CDC and the many promoters of the experimental injections claimed were not in them at all. Among those foreign components are metallic objects as demonstrated previously in this journal by Lee et al. (2022) which are confirmed in our results as described in the following.

The 4 clinical cases reported below, with photographic documentation revealing strange phenomena in their blood, illustrate the range and types of the anomalies found in the microscopic examination of the blood of 94.23% of the 1006 cases (a total of 948 cases that showed the same sorts of abnormalities).

The 4 cases summarized and illustrated here are, according to our understanding and in our opinion as clinical experts,absolutely representative of all 948.

Public Health and Medical Professionals for Transparency

This nonprofit, made up of public health professionals, medical professionals, scientists, and journalists exists solely to obtain and disseminate the data relied upon by the FDA to license COVID-19 vaccines. The organization takes no position on the data other than that it should be made publicly available to allow independent experts to conduct their own review and analyses. Any data received will be made public on this website.

Four days after the Pfizer vaccine was approved for ages 16+, we submitted a Freedom of Information Act Request to the FDA for all of the data within Pfizer’s COVID-19 vaccine biological product file. We have now sued the FDA for not releasing the data.

Follow this link for court documents and for productions of Pfizer’s documents from the FDA.

Covid-19 vaccines and treatments: we must have raw data, now

January 19, 2022 Data should be fully and immediately available for public scrutiny.

In the pages of The BMJ a decade ago, in the middle of a different pandemic, it came to light that governments around the world had spent billions stockpiling antivirals for influenza that had not been shown to reduce the risk of complications, hospital admissions, or death. The majority of trials that underpinned regulatory approval and government stockpiling of oseltamivir (Tamiflu) were sponsored by the manufacturer; most were unpublished, those that were published were ghostwritten by writers paid by the manufacturer, the people listed as principal authors lacked access to the raw data, and academics who requested access to the data for independent analysis were denied.1 2 3 4

Unacceptable delay
Pfizer’s pivotal covid vaccine trial was funded by the company and designed, run, analysed, and authored by Pfizer employees. The company and the contract research organisations that carried out the trial hold all the data.17 And Pfizer has indicated that it will not begin entertaining requests for trial data until May 2025, 24 months after the primary study completion date, which is listed on ClinicalTrials.gov as 15 May 2023 (NCT04368728).

Among regulators, the US Food and Drug Administration is believed to receive the most raw data but does not proactively release them. After a freedom of information request to the agency for Pfizer’s vaccine data, the FDA offered to release 500 pages a month, a process that would take decades to complete, arguing in court that publicly releasing data was slow owing to the need to first redact sensitive information. 2 3 This month, however, a judge rejected the FDA’s offer and ordered the data be released at a rate of 55 000 pages a month. The data are to be made available on the requesting organisation’s website (phmpt.org). https://www.bmj.com/content/376/bmj.o102

Public Health and Medical Professionals for Transparency

This nonprofit, made up of public health professionals, medical professionals, scientists, and journalists exists solely to obtain and disseminate the data relied upon by the FDA to license COVID-19 vaccines. The organization takes no position on the data other than that it should be made publicly available to allow independent experts to conduct their own review and analyses. Any data received will be made public on this website.

Four days after the Pfizer vaccine was approved for ages 16+, we submitted a Freedom of Information Act Request to the FDA for all of the data within Pfizer’s COVID-19 vaccine biological product file. We have now sued the FDA for not releasing the data. Click below for court documents and for productions of Pfizer’s documents from the FDA.

We Should Rethink the Policy

The NNTV (the number needed to vaccinate) is between 200–700 to prevent one case of COVID-19 for the mRNA vaccine marketed by Pfizer, while the NNTV to prevent one death is between 9000 and 50,000 (95% confidence interval), with 16,000 as a point estimate.

The number of cases experiencing adverse reactions has been reported to be 700 per 100,000 vaccinations.

Currently, we see 16 serious side effects per 100,000 vaccinations, and the number of fatal side effects is at 4.11/100,000 vaccinations. For three deaths prevented by vaccination we have to accept two inflicted by vaccination. 

Conclusions: This lack of clear benefit should cause governments to rethink their vaccination policy.

https://www.mdpi.com/2076-393X/9/7/693/htm

INFORMED CONSENT

Informed consent disclosure to vaccine trial subjects of risk of COVID-19 vaccines worsening clinical disease

Results of the study: COVID-19 vaccines designed to elicit neutralising antibodies may sensitise vaccine recipients to more severe disease than if they were not vaccinated. Vaccines for SARS, MERS and RSV have never been approved, and the data generated in the development and testing of these vaccines suggest a serious mechanistic
concern:

that vaccines designed empirically using the traditional approach (consisting of the unmodified or minimally modified coronavirus viral spike to elicit neutralising antibodies), be they composed of protein, viral vector, DNA or RNA and irrespective of delivery method, may worsen COVID-19 disease via antibody-dependent enhancement (ADE).

This risk is sufficiently obscured in clinical trial protocols and consent forms for ongoing COVID-19 vaccine trials that adequate patient comprehension of this risk is unlikely to occur, obviating truly informed consent by subjects in these trials.

CONCLUSION
Given the strong evidence that ADE is a non-theoretical and compelling risk for COVID-19 vaccines and the “laundry list” nature of informed consents, disclosure of the specific risk of worsened COVID-19 disease from vaccination calls for a specific, separate, informed
consent form and demonstration of patient comprehension in order to meet medical ethics standards.

The informed consent process for ongoing COVID-19 vaccine trials does not appear to meet this standard.

While the COVID-19 global health emergency justifies accelerated vaccine trials of candidates with known liabilities, such an acceleration is not inconsistent with additional attention paid to heightened informed consent procedures specific to COVID-19 vaccine risks.

https://pubmed.ncbi.nlm.nih.gov/33113270/

https://onlinelibrary.wiley.com/doi/epdf/10.1111/ijcp.13795

COVID-19 VACCINE INGREDIENTS

Published August 31, 2021 – Updated October 1, 2021

On 20 August 2021 Dr. Robert Young published his team’s findings after analysing the four dominant COVID-19 “vaccines” using Phase Contrast Microscopy, Transmission and Scanning Electron Microscopyand Energy-Dispersive X-ray Spectroscopy. Their research both confirms and expands upon the priorinvestigations carried out by Dr. Pablo Campra (University of Almeria, Spain), Dr. Juan F. Gastón Añaños(Hospital de Barbastro, Spain), as well as the recent pathology reports from autopsies of  vaccinated deceased which were carried out by Prof. Dr. Arne Burkhardt, Prof. Dr. Walter Lang and Prof. Dr. Peter Schirmacher (Germany & Austria). 

Many of these substances were observed as being bonded to graphene oxide and metallic nanoparticles. GO nanoparticles are necrotic, able to pass into or through physiological barriers including (but not limited to) the blood-air barrier, the blood-testis barrier, the blood-brain barrier, and the blood-placenta barrier. Over a period of several months after intramuscular injection, as much as 75% of the GO nanoparticle “delivery platform”, and most of the substances listed below, are transported extensively throughout the bodies of mammals, into the blood, brain and other organs. Some of the many toxic effects of graphene oxide are myocarditis and blood clotting. Contamination in vaccines appears to be so common that one might be forgiven for thinking that it is deliberate.
https://nobulart.com/covid-19-vaccine-ingredients/

Reverse transcription – Genome integration

Potential health risks of mRNA-based vaccine therapy: A hypothesis

K. Acevedo-Whitehouse, R. Bruno
Article 111015
https://www.sciencedirect.com/journal/medical-hypotheses/vol/171/suppl/C

Abstract

Therapeutic applications of synthetic mRNA were proposed more than 30 years ago, and are currently the basis of one of the vaccine platforms used at a massive scale as part of the public health strategy to get COVID-19 under control. To date, there are no published studies on the biodistribution, cellular uptake, endosomal escape, translation rates, functional half-life and inactivation kinetics of synthetic mRNA, rates and duration of vaccine-induced antigen expression in different cell types.

Furthermore, despite the assumption that there is no possibility of genomic integration of therapeutic synthetic mRNA, only one recent study has examined interactions between vaccine mRNA and the genome of transfected cells, and reported that an endogenous retrotransposon, LINE-1 is unsilenced following mRNA entry to the cell, leading to reverse transcription of full length vaccine mRNA sequences, and nuclear entry.

This finding should be a major safety concern, given the possibility of synthetic mRNA-driven epigenetic and genomic modifications arising.

We propose that in susceptible individuals, cytosolic clearance of nucleotide modified synthetic (nms-mRNAs) is impeded. Sustained presence of nms-mRNA in the cytoplasm deregulates and activates endogenous transposable elements (TEs), causing some of the mRNA copies to be reverse transcribed. The cytosolic accumulation of the nms-mRNA and the reverse transcribed cDNA molecules activates RNA and DNA sensory pathways. Their concurrent activation initiates a synchronized innate response against non-self nucleic acids, prompting type-I interferon and pro-inflammatory cytokine production which, if unregulated, leads to autoinflammatory and autoimmune conditions, while activated TEs increase the risk of insertional mutagenesis of the reverse transcribed molecules, which can disrupt coding regions, enhance the risk of mutations in tumour suppressor genes, and lead to sustained DNA damage. Susceptible individuals would then expectedly have an increased risk of DNA damage, chronic autoinflammation, autoimmunity and cancer. In light of the current mass administration of nms-mRNA vaccines, it is essential and urgent to fully understand the intracellular cascades initiated by cellular uptake of synthetic mRNA and the consequences of these molecular events.

https://www.sciencedirect.com/science/article/pii/S0306987723000117/pdfft?md5=534cf48210e10f01456b7fe6853c9aa3&pid=1-s2.0-S0306987723000117-main.pdf

Intracellular Reverse Transcription of Pfizer BioNTech COVID-19 mRNA Vaccine

https://www.mdpi.com/1467-3045/44/3/73
https://doi.org/10.3390/cimb44030073
Academic Editor: Stephen Malnick
Published: 25 February 2022

Abstract: Preclinical studies of COVID-19 mRNA vaccine BNT162b2, developed by Pfizer and BioNTech, showed reversible hepatic effects in animals that received the BNT162b2 injection.

Furthermore, a recent study showed that SARS-CoV-2 RNA can be reverse-transcribed and integrated into the genome of human cells. In this study, we investigated the effect of BNT162b2 on the human liver cell line Huh7 in vitro. Huh7 cells were exposed to BNT162b2, and quantitative PCR was performed on RNA extracted from the cells.

We detected high levels of BNT162b2 in Huh7 cells and changes in gene expression of long interspersed nuclear element-1 (LINE-1), which is an endogenous reverse transcriptase. Immunohistochemistry using antibody binding to LINE-1 open reading frame-1 RNA-binding protein (ORFp1) on Huh7 cells treated with BNT162b2 indicated increased nucleus distribution of LINE-1. PCR on genomic DNA of Huh7 cells exposed to BNT162b2 amplified the DNA sequence unique to BNT162b2. Our results indicate a fast up-take of BNT162b2 into human liver cell line Huh7, leading to changes in LINE-1 expression and distribution.

We also show that BNT162b2 mRNA is reverse transcribed intracellularly into DNA in as fast as 6 h upon BNT162b2 exposure.

Nov 2021 Warning – mRNA COVID Vaccines Dramatically Increase Endothelial Inflammatory Markers

Steven R Gundry – Originally published- 8 Nov 2021
mRNA COVID Vaccines Dramatically Increase Endothelial Inflammatory Markers and ACS Risk as Measured by the PULS Cardiac Test

Abstract
Our group has been using the PLUS Cardiac Test (GD Biosciences, Inc, Irvine, CA) a clinically validated measurement of multiple protein biomarkers which generates a score predicting the 5 yr risk (percentage chance) of a new Acute Coronary Syndrome (ACS).

The score has been measured every 3-6 months in our patient population for 8 years. Recently, with the advent of the mRNA COVID 19 vaccines (vac) by Moderna and Pfizer, dramatic changes in the PULS score became apparent in most patients. This report summarizes those results.

At the time of this report, these changes persist for at least 2.5 months post second dose of vac.

We conclude that the mRNA vacs dramatically increase inflammation on the endothelium and T cell infiltration of cardiac muscle and may account for the observations of increased thrombosis, cardiomyopathy, and other vascular events following vaccination. https://www.ahajournals.org/doi/abs/10.1161/circ.144.suppl_1.10712

Reverse-transcribed SARS-CoV-2 RNA can integrate into the genome of cultured human cells and can be expressed in patient-derived tissues

An unresolved issue of SARS-CoV-2 disease is that patients often remain positive for viral RNA as detected by PCR many weeks after the initial infection in the absence of evidence for viral replication. We show here that SARS-CoV-2 RNA can be reverse-transcribed and integrated into the genome of the infected cell and be expressed as chimeric transcripts fusing viral with cellular sequences.

We present here evidence that SARS-CoV-2 sequences can be reverse-transcribed and integrated into the DNA of infected human cells in culture. ….
These and other data are consistent with a target primed reverse transcription and retroposition integration mechanism and suggest that endogenous LINE1 RT can be involved in the reverse transcription and integration of SARS-CoV-2 sequences in the genomes of infected cells.

Our results may also be relevant for current clinical trials of antiviral therapies. If integration and expression of viral RNA are fairly common, reliance on extremely sensitive PCR tests to determine the effect of treatments on viral replication and viral load may not always reflect the ability of the treatment to fully suppress viral replication because the PCR assays may detect viral transcripts that derive from viral DNA sequences that have been stably integrated into the genome rather than infectious virus. 
https://www.pnas.org/content/118/21/e2105968118

SARS-CoV-2 sequences transcribed in DNA detected in the genome of infected cells

Original article in German https://www.scinexx.de/news/medizin/coronavirus-dna-auch-in-unserem-erbgut read with Google translate

Surprising discovery: even though the coronavirus is an RNA virus, parts of its genome can be inserted into our DNA. This is proven by gene sequences of the virus in the DNA of cell cultures and in the tissues of Covid-19 patients.

Twitter comment from Pieter borger (MSc, PhD molecular genetics)
“Very interesting read. Every RNA molecule can potentially integrate in the genome because the two enzymes required to do so Reverse Transcriptase (RT) and integrase (INT) are 1000-fold present in our genome.”

Researchers led by Liguo Zhang from the Whitehead Institute for Biomedical Research in Cambridge have now investigated whether an infection with this virus can still leave genetic traces in the human genome. The impetus for this was provided by Covid patients whose PCR tests were still positive or positive again even months after the acute infection.

“We found copies of DNA from parts of the viral genome in almost all human chromosomes,” the team reports.”

SARS-CoV-2 spike protein can cause major damage to the walls of blood vessels.

“If you remove the replicating capabilities of the virus, it still has a major damaging effect on the vascular cells, simply by virtue of its ability to bind to this ACE2 receptor, the S protein receptor”

The novel coronavirus’ spike protein plays additional key role in illness

The paper, published on April 30, 2021, in Circulation Research, also shows conclusively that COVID-19 is a vascular disease, demonstrating exactly how the SARS-CoV-2 virus damages and attacks the vascular system on a cellular level. The findings help explain COVID-19’s wide variety of seemingly unconnected complications, and could open the door for new research into more effective therapies.

In the new study, the researchers created a “pseudovirus” that was surrounded by SARS-CoV-2 classic crown of spike proteins, but did not contain any actual virus. Exposure to this pseudovirus resulted in damage to the lungs and arteries of an animal model—proving that the spike protein alone was enough to cause disease.

COVID-19 RNA Based Vaccines and the Risk of Prion Disease

ABSTRACT
Development of new vaccine technology has been plagued with problems in the past. The current RNA based SARS- CoV-2 vaccines were approved in the US using an emergency order without extensive long term safety testing.

In this paper the Pfizer COVID-19 vaccine was evaluated for the potential to induce prion-based disease in vaccine recipients. The RNA sequence of the vaccine as well as the spike protein target interaction were analyzed for the potential to convert intracellular RNA binding proteins TAR DNA binding protein (TDP-43) and Fused in Sarcoma (FUS) into their pathologic prion conformations.

The results indicate that the vaccine RNA has specific sequences that may induce TDP-43 and FUS to fold into their pathologic prion confirmations. In the current analysis a total of sixteen UG tandem repeats (ΨGΨG) were identified and additional UG (ΨG) rich sequences were identified. Two GGΨA sequences were found. Potential G Quadruplex sequences are possibly present but a more sophisticated computer program is needed to verify these. Furthermore, the spike protein, created by the translation of the vaccine RNA, binds angiotensin converting enzyme 2 (ACE2), a zinc containing enzyme. This interaction has the potential to increase intracellular zinc. Zinc ions have been shown to cause the transformation of TDP-43 to its pathologic prion configuration. The folding of TDP-43 and FUS into their pathologic prion confirmations is known to cause ALS, front temporal lobar degeneration, Alzheimer’s disease and other neurological degenerative diseases.

The enclosed finding as well as additional potential risks leads the author to believe that regulatory approval of the RNA based vaccines for SARS-CoV-2 was premature and that the vaccine may cause much more harm than benefit.

https://scivisionpub.com/pdfs/covid19-rna-based-vaccines-and-the-risk-of-prion-disease-1503.pdf

36 COVID-19 vaccine recipients develop rare blood disorder after getting Moderna, Pfizer

This Side-Effect Is Not Age Or Gender Specific
Earlier this week, a report in the New York Times highlighted the fact that around 36 reports of this rare blood disorder, also called immune thrombocytopenia (ITP), was submitted to the federal government’s Vaccine Adverse Event Reporting System (VAERS).

A Florida physician has also reportedly died of the condition in January. The cases are equally divided between Pfizer and Moderna, manufacturers of the two COVID vaccines currently approved in the US, and they don’t seem to be age- or gender-specific. But experts are not very sure if the shots really did cause the problem, or if these people developed immune thrombocytopenia anyway. Some think that it is just a coincidence that symptoms surfaced post-vaccination.

https://www.thehealthsite.com/news/36-covid-19-vaccine-recipients-develop-rare-blood-disorder-after-getting-moderna-pfizer-shots-795552/

Rudolf Jaenisc – SARS-CoV-2 RNA reverse-transcribed and integrated into the human genome

Prolonged SARS-CoV-2 RNA shedding and recurrence of PCR-positive tests have been widely reported in patients after recovery, yet these patients most commonly are non-infectious^1–14.
Here we investigated the possibility that SARS-CoV-2 RNAs can be reverse-transcribed and integrated into the human genome and that transcription of the integrated sequences might account for PCR-positive tests.
In support of this hypothesis, we found chimeric transcripts consisting of viral fused to cellular sequences in published data sets of SARS-CoV-2 infected cultured cells and primary cells of patients, consistent with the transcription of viral sequences integrated into the genome. 
In this study, we showed evidence that SARS-CoV-2 RNAs can be reverse-transcribed and integrated into the human genome by several sources of reverse transcriptase such as activated human LINE-1 or co-infected retrovirus (HIV). We found LINE-1 expression can be induced upon SARS-CoV-2 infection or cytokine exposure, suggesting a molecular mechanism responsible for SARS-CoV-2 retro-integration in patients.
Moreover, our results suggest that the integrated SARS-CoV-2 sequences can be transcribed, as shown by RNA-Seq and smRNA-FISH data, providing a possible explanation for the presence of viral sequences at later times after initial virus exposure and in the absence of detectable infectious virus^1–14.

Biography Rudolf Jaenisch; one of the co-writers in this study
Whitehead Institute for Biomedical Research, Cambridge, MA, USA Department of Biology, Massachusetts Institute of Technology, Cambridge, MA, USA
https://www.pnas.org/content/101/39/13982

https://www.biorxiv.org/content/10.1101/2020.12.12.422516v1

Study: SARS-CoV-2 RNA can be reverse-transcribed to be part of chimeric viral-human genome.

A study appearing as a preprint on the bioRxiv* server in December 2020 reveals that the genome of the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is inserted into the human genome, accounting for the detection of viral RNAs,  even in late convalescence.
Multiple cases of apparent reinfection have been reported over the past year. Though some have been rigorously investigated and found to be genuine cases of reinfection, evidenced by the presence of different strains of SARS-CoV-2 in the two episodes, it seems unlikely that this is the case with most. Additionally, no replication-competent virus has been isolated.

Implications and future directions

“Our results show induced LINE-1 expression in cells stressed by viral infection or exposed to cytokines, suggesting a molecular mechanism for SARS-CoV-2 retro-integration in human cells.”

• Chimeric reads present in published RNA sequences
• Sources of RT activity: LINE-1 or HIV-1
• N sequences found in the cell nucleus
• LINE-1 and cytokines mediate reverse transcription

Full article online:
https://www.news-medical.net/news/20201216/SARS-CoV-2-RNA-can-be-reverse-transcribed-to-be-part-of-chimeric-viral-human-genome.aspx

Informed consent disclosure to vaccine trial subjects of risk of COVID‐19 vaccines worsening clinical disease

Results of the study
COVID‐19 vaccines designed to elicit neutralising antibodies may sensitise vaccine recipients to more severe disease than if they were not vaccinated. Vaccines for SARS, MERS and RSV have never been approved, and the data generated in the development and testing of these vaccines suggest a serious mechanistic concern: that vaccines designed empirically using the traditional approach (consisting of the unmodified or minimally modified coronavirus viral spike to elicit neutralising antibodies), be they composed of protein, viral vector, DNA or RNA and irrespective of delivery method, may worsen COVID‐19 disease via antibody‐dependent enhancement (ADE). This risk is sufficiently obscured in clinical trial protocols and consent forms for ongoing COVID‐19 vaccine trials that adequate patient comprehension of this risk is unlikely to occur, obviating truly informed consent by subjects in these trials.

Conclusions drawn from the study and clinical implications
The specific and significant COVID‐19 risk of ADE should have been and should be prominently and independently disclosed to research subjects currently in vaccine trials, as well as those being recruited for the trials and future patients after vaccine approval, in order to meet the medical ethics standard of patient comprehension for informed consent.

1 THE RISK OF ADE IN COVID‐19 VACCINES IS NON‐THEORETICAL AND COMPELLING
2 CHALLENGES TO INFORMED CONSENT FOR COVID‐19 VACCINE STUDIES
3 CONCLUSION

Given the strong evidence that ADE is a non‐theoretical and compelling risk for COVID‐19 vaccines and the “laundry list” nature of informed consents, disclosure of the specific risk of worsened COVID‐19 disease from vaccination calls for a specific, separate, informed consent form and demonstration of patient comprehension in order to meet medical ethics standards. The informed consent process for ongoing COVID‐19 vaccine trials does not appear to meet this standard. While the COVID‐19 global health emergency justifies accelerated vaccine trials of candidates with known liabilities, such an acceleration is not inconsistent with additional attention paid to heightened informed consent procedures specific to COVID‐19 vaccine risks.

First published: 28 October 2020 https://doi.org/10.1111/ijcp.13795

Dr Doug -Will an RNA Vaccine Permanently Alter My DNA?

Posted by Dr. Doug November 27, 2020 Posted in COVID-19, vaccine

My professional opinion is that since RNA vaccines are a new mode of delivering vaccines, they should be tested for 5-10 years to demonstrate that genetic modification is not a major concern.

In addition, all coronavirus vaccines, regardless of type, should be tested for an equal duration to show that ADE is not a concern.

It is absolutely impossible to rule out these safety concerns in less than a year.

Will an RNA Vaccine Permanently Alter My DNA?

Antibody-dependent enhancement and SARS-CoV-2 vaccines and therapies

9 September 2020 https://www.nature.com/articles/s41564-020-00789-5#Sec10

Data from the study of SARS-CoV and other respiratory viruses suggest that anti-SARS-CoV-2 antibodies could exacerbate COVID-19 through antibody-dependent enhancement (ADE). Previous respiratory syncytial virus and dengue virus vaccine studies revealed human clinical safety risks related to ADE, resulting in failed vaccine trials.

ADE has been observed in SARS, MERS and other human respiratory virus infections including RSV and measles, which suggests a real risk of ADE for SARS-CoV-2 vaccines and antibody-based interventions. However, clinical data has not yet fully established a role for ADE in human COVID-19 pathology. Steps to reduce the risks of ADE from immunotherapies include the induction or delivery of high doses of potent neutralizing antibodies, rather than lower concentrations of non-neutralizing antibodies that would be more likely to cause ADE.

Going forwards, it will be crucial to evaluate animal and clinical datasets for signs of ADE, and to balance ADE-related safety risks against intervention efficacy if clinical ADE is observed. Ongoing animal and human clinical studies will provide important insights into the mechanisms of ADE in COVID-19. Such evidence is sorely needed to ensure product safety in the large-scale medical interventions that are likely required to reduce the global burden of COVID-19.

Dr Peter Borger -The facts are that RNA vaccins can potentially change your DNA

The science facts are that RNA vaccins can potentially change your DNA. To understand how, we have to go a bit into genomics. Our genome contains about 50-60 thousand genes (~20 thousand protein-coding genes, the rest RNA genes). Together they make up about 25% of the genome.

In addition to that, our genome contains about 50% so called transposable and transposed elements (TEs), including ERVs and LINEs. The latter function, among other things, as (epi)genetic switches to control when genetic programs are switched on and off.

Interestingly, ERVs and LINEs both posses genes for the enzymes “reverse transcriptase (RT)” and “integrase” (INT). The RT enzyme converts RNA into cDNA, whereas the INT enzyme can put cDNA back into the genome. They prefer doing this with viral-like RNA molecules.

Further, RNA vaccins use viruses as their genetic backbones. RNA vaccins contain viral RNAs. With thousands of copies of RT and INT genes in our genomes there is ample opportunity to put any viral RNA back into our DNA. So, RNA vaccins are potentially “genotoxic”.

“Genotoxic” means that the “RNA–>cDNA–>genome integration” mechanism can lead to disturbed genetic control. In the long run, that may lead to genetic abberations and disease. It should be noted that RNA vaccins were not tested to exclude above described genotoxicy.

Above text copied from Tweet below

Snopes' "fact checkers" are wrong about mRNA vaccins:https://t.co/7qse8j6cxc

Snopes, who claims to do fact checking, writes:

"No, mRNA COVID vaccines do not alter your DNA".

Snopes did not even begin to check the science facts.

— Pieter Borger (@BorgerPieter) December 17, 2020

Dr Andrew Wakefield -Messenger RNA vaccine is actually genetic engineering

Explaining why by definition a RNA vaccine isn’t a vaccine at all.
What could possibly go wrong, the potential for this to go horribly wrong is enormous it’s never been used in humans before it’s never been tested out and yet it’s been rushed to market. No liability for vaccines so they can shortcuts safety studies they can rush to market they don’t mind because they’re not going to pay a price for it they don’t pick up the tab for the damage done. The full interview in a pdf for download below the video

And for those who would like to discredit Dr Andrew Wakefield listen to the video below:
Del Bigtree sets the record straight over Andrew Wakefield

An Evidence Based Perspective on mRNA-SARS-CoV-2 Vaccine Development

Although these beneficial features of mRNA vaccines provide some hope for the development of the first clinically applicable SARS-CoV-2 mRNA vaccine, recent reports regarding rare cases of moderate or severe reactions for different mRNA vaccines have raised concerns about safety and immunogenicity, including in the primary outcome findings of the phase I trial on mRNA-1273 [20,48]. Therefore, it is important to clearly understand the potential risks of this type of mRNA-based vaccine, which include local and systemic inflammatory responses, the biodistribution and persistence of the induced immunogen expression, possible development of autoreactive antibodies and toxic effects of any non-native nucleotides and delivery system components [48–50].

Therefore, it is important to clearly understand the potential risks of this type of mRNA-based vaccine, which include local and systemic inflammatory responses, the biodistribution and persistence of the induced immunogen expression, possible development of autoreactive antibodies and toxic effects of any non-native nucleotides and delivery system components [48–50].

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7218962/

mRNA vaccines — a new era in vaccinology

Nature Reviews Drug Discovery volume 17, 261–279(2018)

Potential safety concerns that are likely to be evaluated in future preclinical and clinical studies include local and systemic inflammation, the biodistribution and persistence of expressed immunogen, stimulation of auto-reactive antibodies and potential toxic effects of any non-native nucleotides and delivery system components.
A possible concern could be that some mRNA-based vaccine platforms^54,166 induce potent type I interferon responses, which have been associated not only with inflammation but also potentially with autoimmunity^167,16.
Thus, identification of individuals at an increased risk of autoimmune reactions before mRNA vaccination may allow reasonable precautions to be taken.

Conclusions
While preclinical studies have generated great optimism about the prospects and advantages of mRNA-based vaccines, two recent clinical reports have led to more tempered expectations^22,91. In both trials, immunogenicity was more modest in humans than was expected based on animal models, a phenomenon also observed with DNA-based vaccines¹⁷¹, and the side effects were not trivial. 

https://www.nature.com/articles/nrd.2017.243

Transplacental Transmission of the COVID-19 Vaccine mRNA

Evidence from Placental, Maternal and Cord Blood Analyses Post-Vaccination.
Accepted Date: 24 January 2024
Lin X, Botros B, Hanna M, Gurzenda E, Manzano De Mejia C, Chavez M, Hanna N, “Transplacental Transmission of the COVID-19 Vaccine mRNA: Evidence from Placental,
Maternal and Cord Blood Analyses Post-Vaccination”, American Journal of Obstetrics and Gynecology (2024), doi: https://doi.org/10.1016/j.ajog.2024.01.022

Our findings suggest that the vaccine mRNA is not localized to the injection site and can spread 100 systemically to the placenta and umbilical cord blood. 
The detection of the spike protein in the 101 placental tissue indicates the bioactivity of the vaccine mRNA reaching the placenta. Notably, the 102 vaccine mRNA was largely fragmented in the cord blood and, to a lesser extent, in the placenta. 103 To our knowledge, these two cases demonstrate, for the first time, the ability of the COVID-19 104 vaccine mRNA to penetrate the fetal-placental barrier and reach the intrauterine environment.

In a Twist, Scientists Find Cancer Drivers Hiding in RNA, Not DNA

2 Articles …

1) the original publication from 2018 – the Sloan Kettering Institute

Researchers at the Sloan Kettering Institute have found that changes in an information-carrying molecule called messenger RNA can inactivate tumor-suppressing proteins and thereby promote cancer. The findings pinpoint previously unknown drivers of the disease.

https://www.mskcc.org/news/scientists-find-cancer-drivers-hiding-rna-not-dna

2) Sceptic article from Naturalnews alarming the effect mRNA vaccination

MEDICAL SHOCKER: Scientists at Sloan Kettering discover mRNA inactivates tumor-suppressing proteins, meaning it can promote cancer.

After your Covid vaccination, RNA is transported out of your cell’s nucleus, and will no longer function properly as a cancer tumor suppressor

https://www.naturalnews.com/2021-03-02-scientists-discover-mrna-inactivates-tumor-suppressing-proteins.html#

Widespread intronic polyadenylation inactivates tumour suppressor genes in leukaemia

DNA mutations are known cancer drivers. Here we investigated whether mRNA events that are upregulated in cancer can functionally mimic the outcome of genetic alterations.

RNA sequencing or 3′-end sequencing techniques were applied to normal and malignant B cells from 59 patients with chronic lymphocytic leukaemia (CLL)^1,2,3.

We discovered widespread upregulation of truncated mRNAs and proteins in primary CLL cells that were not generated by genetic alterations but instead occurred by intronic polyadenylation. Truncated mRNAs caused by intronic polyadenylation were recurrent (n = 330) and predominantly affected genes with tumour-suppressive functions. The truncated proteins generated by intronic polyadenylation often lack the tumour-suppressive functions of the corresponding full-length proteins (such as DICER and FOXN3), and several even acted in an oncogenic manner (such as CARD11, MGA and CHST11). In CLL, the inactivation of tumour-suppressor genes by aberrant mRNA processing is substantially more prevalent than the functional loss of such genes through genetic events. We further identified new candidate tumour-suppressor genes that are inactivated by intronic polyadenylation in leukaemia and by truncating DNA mutations in solid tumours^4,5.

These genes are understudied in cancer, as their overall mutation rates are lower than those of well-known tumour-suppressor genes. Our findings show the need to go beyond genomic analyses in cancer diagnostics, as mRNA events that are silent at the DNA level are widespread contributors to cancer pathogenesis through the inactivation of tumour-suppressor genes.

https://www.nature.com/articles/s41586-018-0465-8

Natural Immunity – Had COVID? You’ll probably make antibodies for a lifetime

Natural immunity to SARS-CoV-2 (obtained by infection) and vaccine-generated immunity to SARS-CoV2 are two different paths to immunity.

20+ studies on this page

Antibody Evolution after SARS-CoV-2 mRNA Vaccination

We conclude that memory antibodies selected over time by natural infection have greater potency and breadth than antibodies elicited by vaccination.

These results suggest that boosting vaccinated individuals with currently available mRNA vaccines would produce a quantitative increase in plasma neutralizing activity but not the qualitative advantage against variants obtained by vaccinating convalescent individuals.

https://www.biorxiv.org/content/10.1101/2021.07.29.454333v1

Covid-19 vaccine efficacy and effectiveness

Worldwide Bayesian Causal Impact Analysis of Vaccine

November 15, 2021
Worldwide Bayesian Causal Impact Analysis of Vaccine Administration on Deaths and Cases Associated with COVID-19: A BigData Analysis of 145 Countries

Policy makers and mainstream news anchors have promised the public that the COVID-19 vaccine rollout worldwide would reduce symptoms, and thereby cases and deaths associated with COVID-19. While this vaccine rollout is still in progress, there is a large amount of public data available that permits an analysis of the effect of the vaccine rollout on COVID-19 related cases and deaths. Has this public policy treatment produced the desired effect?

The statistically significant and overwhelmingly positive causal impact after vaccine deployment on the dependent variables total deaths and total cases per million should be highly worrisome for policy makers. They indicate a marked increase in both COVID-19 related cases and death due directly to a vaccine deployment that was originally sold to the public as the “key to gain back our freedoms.” The effect of vaccines on total cases per million and its low positive association with total vaccinations per hundred signifies a limited impact of vaccines on lowering COVID-19 associated cases. These results should encourage local policy makers to make policy decisions based on data, not narrative, and based on local conditions, not global or national mandates. These results should also encourage policy makers to begin looking for other avenues out of the pandemic aside from mass vaccination campaigns.

https://vector-news.github.io/editorials/CausalAnalysisReport_html.html

Effectiveness of the Coronavirus Disease 2019 (COVID-19) Bivalent Vaccine

The association of increased risk of COVID-19 with higher numbers of prior vaccine doses in our study, was unexpected.

A simplistic explanation might be that those who received more doses were more likely to be individuals at higher risk of COVID-19. A small proportion of individuals may have fit this description. However, the majority of subjects in this study were generally young individuals and all were eligible to have received at least 3 doses of vaccine by the study start date, and which they had every opportunity to do.

Therefore, those who received fewer than 3 doses (>45% of individuals in the study) were not those ineligible to receive the vaccine, but those who chose not to follow the CDC’s recommendations on remaining updated with COVID-19 vaccination, and
one could reasonably expect these individuals to have been more likely to have exhibited higher risk taking behavior.

Despite this, their risk of acquiring COVID-19 was lower than those who received a larger number of prior vaccine doses.

This is not the only study to find a possible association with more prior vaccine doses and higher risk of COVID-19. A

https://www.medrxiv.org/content/10.1101/2022.12.17.22283625v1.full.pdf

Three studies published by the CDC, British government & Oxford University conclude that Covid-19 Vaccines do not work

September 9, 2021 Nina Pierpont, MD, PhD
Covid-19 vaccines do not keep people from catching the prevailing Delta variant and passing it to others

• Excellent scientific research papers published or posted in August 2021 clearly demonstrate that current vaccines do not prevent transmission of SARS-CoV-2.
  
• Vaccines aim to achieve two ends:
  • To protect the vaccinated person against the illness.
  • To keep people from carrying the infection and transmitting it to others.
    • If enough people are vaccinated or otherwise become immune, it is hoped that thedisease will stop circulating. We call this herd immunity.
    • On the way to herd immunity, there is an assumption that people who are immunized canform safe clusters or groups within which no one is carrying or transmitting the virus.

• Unfortunately, this last assumption (2.b.ii) is no longer true under the new variant of SARS-CoV- 2, Delta( B.1.617.2), which now accounts for essentially all cases worldwide.

• Delta is more infectious than the Alpha strain (B.1.1.7) that prevailed in the UK from January to May 2021 (and in the US from March to June 2021), meaning that Delta is passed more readily person-to-person than the previous dominant strain.
  – Infectiousness is a correlate of high viral load (see section 5, below).
  – From its origin in India, Delta has soared to nearly complete domination of COVID-19 viral strains everywhere in a matter of months, because it spreads so easily and infects both vaccinated and unvaccinated people.

• New research in multiple settings shows that Delta produces very high viral loads (meaning, the densityof virus on a nasopharyngeal swab as interpreted from PCR cycle threshold numbers).
  • Viral loads are much higher in people infected with Delta than they were in people infected withAlpha.
  • Viral loads with Delta are equally high whether the person has been vaccinated or not.
  • Viral load is an indicator of infectiousness. [13,14] The more virus one has in the nose and mouth, the more likely it is to be in this individual’s respiratory droplets and secretions, and tospread to others.

• Due to evolution of the virus itself, all the currently licensed vaccines (all based on the original Wuhanstrain spike protein sequence) have lost their ability to accomplish vaccine purpose 2(b), above, “To keeppeople from carrying the infection and transmitting it to others.”

• Vaccine mandates are thus stripped of their justification, since to vaccinate an individual no longerstops or even slows his ability to acquire and transmit the virus to others

• Under Delta, natural immunity is much more protective than vaccination. All severities of COVID-19 illness produce healthy levels of natural immunity.

Increases in COVID-19 are unrelated to levels of vaccination across 68 countries and 2947 counties in the United States

September 2021
Vaccines currently are the primary mitigation strategy to combat COVID-19 around the world.

For instance, the narrative related to the ongoing surge of new cases in the United States (US) is argued to be driven by areas with low vaccination rates [1].

A similar narrative also has been observed in countries, such as Germany and the United Kingdom [2].

At the same time, Israel that was hailed for its swift and high rates of vaccination has also seen a substantial resurgence in COVID-19 cases [3].

We investigate the relationship between the percentage of population  fully vaccinated and new COVID-19 cases across 68 countries and across 2947 counties in the US.

Both countries have over 75% of their population fully vaccinated and have more COVID-19 cases per 1 million people than countries such as Vietnam and South Africa that have around 10% of their population fully vaccinated.

https://link.springer.com/article/10.1007/s10654-021-00808-7

Nosocomial outbreak caused by the SARS-CoV-2 Delta variant in a highly vaccinated population, Israel, July 2021

We present an investigation of a coronavirus disease (COVID-19) outbreak that started from one unidentified COVID-19 patient, with extensive, rapid nosocomial spread among vaccinated, including individuals wearing surgical masks.

Discussion ” … all transmissions between patients and staff occurred between masked and vaccinated individuals … “

Conclusion “This nosocomial outbreak exemplifies the high transmissibility of the SARS-CoV-2 Delta variant among twice vaccinated and masked individuals… “

https://www.eurosurveillance.org/content/10.2807/1560-7917.ES.2021.26.39.2100822

Is the Pfizer vaccine as effective as claimed?

May 17, 2021 Norman Fenton and Martin Neil

There are, however, issues with the study and its analysis which mean the 95% effectiveness measure is exaggerated. In this article Will Jones argues that the researchers have not adjusted for the declining infection rate during the study period and that when you do so, the effectiveness drops to 74% (in the over 65’s). 

https://wherearethenumbers.substack.com/p/important-caveats-to-pfizer-vaccine

The elephant (not) in the room

COVID-19 vaccine efficacy and effectiveness—the elephant (not) in the room
Lancet Microbe April 20, 2021 https://doi.org/10.1016/ S2666-5247(21)00069-0

Excerpts of these results have been widely communicated and debated through press releases and media, sometimes in misleading ways. Although attention has focused on vaccine efficacy and comparing the reduction of the number of symptomatic cases, fully understanding the efficacy and effectiveness of vaccines is less straightforward than it might seem. Depending on how the effect size is expressed, a quite different picture might emerge.

Although the  relative risk reduction (RRR) considers only participants who could benefit from the vaccine, the absolute risk reduction (ARR), which is the difference between attack rates with and without a vaccine, considers the whole population.

ARRs tend to be ignored because they give a much less impressive effect size than RRRs:

• 1.3% for the AstraZeneca–Oxford
• 1.2% for the Moderna–NIH
• 1.2% for the J&J
• 0.93% for the Gamaley
• 0.84% for the Pfizer–BioNTech vaccines

Outcome Reporting Bias in COVID-19 mRNA Vaccine Clinical Trials

Received: 13 January 2021 / Revised: 15 February 2021 / Accepted: 22 February 2021 / Published: 26 February 2021

Abstract
Relative risk reduction and absolute risk reduction measures in the evaluation of clinical trial data are poorly understood by health professionals and the public.

The absence of reported absolute risk reduction in COVID-19 vaccine clinical trials can lead to outcome reporting bias that affects the interpretation of vaccine efficacy.

The present article uses clinical epidemiologic tools to critically appraise reports of efficacy in Pfzier/BioNTech and Moderna COVID-19 mRNA vaccine clinical trials.
Based on data reported by the manufacturer

For Pfzier/BioNTech vaccine BNT162b2, this critical appraisal shows:
relative risk reduction, 95.1%; 95% CI, 90.0% to 97.6%; p = 0.016;
absolute risk reduction, 0.7%; 95% CI, 0.59% to 0.83%; p < 0.000.

For the Moderna vaccine mRNA-1273, the appraisal shows:
relative risk reduction, 94.1%; 95% CI, 89.1% to 96.8%; p = 0.004;
absolute risk reduction, 1.1%; 95% CI, 0.97% to 1.32%; p < 0.000.

Unreported absolute risk reduction measures of 0.7% and 1.1% for the Pfzier/BioNTech and Moderna vaccines, respectively, are very much lower than the reported relative risk reduction measures.

Reporting absolute risk reduction measures is essential to prevent outcome reporting bias in evaluation of COVID-19 vaccine efficacy.

Conclusions
A critical appraisal of phase III clinical trial data for the Pfizer/BioNTech vaccine BNT162b2 and Moderna vaccine mRNA-1273 shows that absolute risk reduction measures are very much lower than the reported relative risk reduction measures.

Yet, the manufacturers failed to report absolute risk reduction measures in publicly released documents.

As well, the U.S FDA Advisory Committee (VRBPAC) did not follow FDA published guidelines for communicating risks and benefits to the public, and the committee failed to report absolute risk reduction measures in authorizing the BNT162b2 and mRNA-1273 vaccines for emergency use.

Such examples of outcome reporting bias mislead and distort the public’s interpretation of COVID-19 mRNA vaccine efficacy and violate the ethical and legal obligations of informed consent. https://www.mdpi.com/1648-9144/57/3/199/htm

Pfizer Covid-19 vaccine candidate is unimpressive: NNTV is around 256

Pfizer’s vaccine “may be more than 90% effective.” (Mahase, BMJ 2020;371:m4347, November 9)

Specific data are not given but it is easy enough to approximate the numbers involved, based on the 94 cases in a trial that has enrolled about 40,000 subjects: 8 cases in a vaccine group of 20,000 and 86 cases in a placebo group of 20,000.

This yields a Covid-19 attack rate of 0.0004 in the vaccine group and 0.0043 in the placebo group. Relative risk (RR) for vaccination = 0.093, which translates into a “vaccine effectiveness” of 90.7% [100(1-0.093)]. This sounds impressive, but the absolute risk reduction for an individual is only about 0.4% (0.0043-0.0004=0.0039).

The Number Needed To Vaccinate (NNTV) = 256 (1/0.0039), which means that to prevent just 1 Covid-19 case 256 individuals must get the vaccine; the other 255 individuals derive no benefit, but are subject to vaccine adverse effects, whatever they may be and whenever we learn about them
https://www.bmj.com/content/371/bmj.m4347/rr-4

Vaccine Makers Claim COVID Shots Are ‘95% Effective’ — But What Does That Mean?

Peter Doshi: Pfizer and Moderna’s “95% effective” vaccines—let’s be cautious and first see the full data

Let’s put this in perspective.

– First, a relative risk reduction is being reported, not absolute risk reduction, which appears to be less than 1%.

– Second, these results refer to the trials’ primary endpoint of covid-19 of essentially any severity, and importantly not the vaccine’s ability to save lives, nor the ability to prevent infection, nor the efficacy in important subgroups (e.g. frail elderly). Those still remain unknown.

– Third, these results reflect a time point relatively soon after vaccination, and we know nothing about vaccine performance at 3, 6, or 12 months, so cannot compare these efficacy numbers against other vaccines like influenza vaccines (which are judged over a season).

– Fourth, children, adolescents, and immunocompromised individuals were largely excluded from the trials, so we still lack any data on these important populations.

Peter Doshi: Pfizer and Moderna’s “95% effective” vaccines—let’s be cautious and first see the full data

Covid Vaccines: The Good, The Bad, The Ugly

Updated: July 27, 2021 – Check the link for updates to this article
Published: July 23, 2021

New data from Hebrew University shows that protection against severe disease has already dropped to 80%; compared to the original 96%, this results in a five-fold increase in residual risk.

New data from Israel shows that 80% of fully vaccinated people haven’t infected others in public spaces. While authorities claim that this is a good result, in reality, it is not any different from unvaccinated people, thus confirming zero effectiveness against infection and transmission.

Thus, vaccine protection even against severe disease will likely further decrease due to new variants, or, in the very worst case, will turn into antibody-dependent disease enhancement (ADE), if high levels of non-neutralizing antibodies aggravate the infection. Indeed, this is what happened in the case of vaccines against SARS-1 and dengue fever.

However, there is a very real risk that additional vaccinations, which inject or induce the coronavirus spike protein, could substantially increase the risk of serious cardiovascular and neurological adverse events, such as strokes, GBS and heart muscle inflammation. Globally, covid vaccines may already have killed tens of thousands of people. Alternatives include safer oral vaccine candidates or medically supervised, low-dose oral live virus challenges in low-risk people.

In conclusion, and as argued previously, vaccine protection against infection and “mild disease” has pretty much collapsed, whereas protection against severe disease and death remains at a reasonable level, with the partial exception of the most senior citizens and especially nursing home residents, some of whom have never mounted a neutralizing antibody response to the vaccine. Moreover, future coronavirus variants will likely achieve additional immune evasion.

Reduced BNT162b2 mRNA vaccine response in SARS-CoV-2-naive nursing home residents

Abstract
The SARS-CoV-2 pandemic impact on nursing home (NH) residents prompted their prioritization for early vaccination.

To fill the data gap for vaccine immunogenicity in NH residents, we examined antibody levels after BNT162b2 mRNA vaccine to spike, receptor binding domain (RBD) and for virus neutralization in 149 NH residents and 111 health care worker controls. SARS-CoV-2-naive

NH residents mount antibody responses with nearly 4-fold lower median neutralization titers and half the anti-spike level compared to SARS-CoV-2-naive healthcare workers.

By contrast, SARS-CoV-2-recovered vaccinated NH residents had neutralization, anti-spike and anti-RBD titers similar to SARS-CoV-2-recovered vaccinated healthcare workers.

NH residents’ blunted antibody responses have important implications regarding the quality and durability of protection afforded by neoantigen vaccines. We urgently need better longitudinal evidence on vaccine effectiveness specific to NH resident populations to inform best practices for NH infection control measures, outbreak prevention and potential indication for a vaccine boost.

https://www.medrxiv.org/content/10.1101/2021.03.19.21253920v1

Dr. Simone Gold – The truth about the CV19 vaccine

Dr Simone Gold, talking about new experimental mRNA vaccine, safte, effectivens and in the beginning a couple of minutes about her experience with HCQ but most of this video is about the.

what are the concerns regarding the effectiveness:

Super shocking is that there’s no proof that this biological agent actually stops the transmission amongst people!!

I mean it’s like it’s like a joke right, it’s like the punchline to a joke “let’s take a vaccine and by the way it doesn’t actually stop transmission “

And by the way this is not disputed, it’s been well documented that they do not known if it stops transmission

Is it like putting people into sort of an asymptomatic carrier, turning positive and becoming the new positives! People taking the vaccine and now they’re testing positive for COVID-19 is kind of funny!
Are they going to test positive forever!? 10s or hundreds of millions running around just kind of positive; what does that mean? Are they going to tell us that the cases have risen!?

Jan Bonte (Hommel) – the Pfizer / BionTech SARS-CoV-2 virus Vaccin

A fantastic piece from Jan Bonte (Dutch Neurologist) detailing the Pfizer vaccin with all it’s unknowns in respect of efficacy, side- and adverse effects.

Too bad; only a few on this planet master the Dutch language… but with the help of online translators

This link directs you to the original blog …select your language of choice with this link to google translate ; this link to Microsoft web translator

Enjoy reading

ROADMAP FOR THE IMPLEMENTATION OF ACTIONS BY THE EUROPEAN COMMISSION BASED ON THE COMMISSION COMMUNICATION AND THE COUNCIL RECOMMENDATION ON STRENGTHENING COOPERATION AGAINST VACCINE PREVENTABLE DISEASES

Will covid-19 vaccines save lives? Current trials aren’t designed to tell us

The world has bet the farm on vaccines as the solution to the pandemic, but the trials are not focused on answering the questions many might assume they are. Peter Doshi reports

As phase III trials of covid-19 vaccines reach their target enrolments, officials have been trying to project calm. The US coronavirus czar Anthony Fauci and the Food and Drug Administration leadership have offered public assurances that established procedures will be followed. Only a “safe and effective” vaccine will be approved, they say, and nine vaccine manufacturers issued a rare joint statement pledging not to prematurely seek regulatory review.

But what will it mean exactly when a vaccine is declared “effective”? To the public this seems fairly obvious. “The primary goal of a covid-19 vaccine is to keep people from getting very sick and dying,” a National Public Radio broadcast said bluntly.

…Yet the current phase III trials are not actually set up to prove either. None of the trials currently under way are designed to detect a reduction in any serious outcome such as hospital admissions, use of intensive care, or deaths. Nor are the vaccines being studied to determine whether they can interrupt transmission of the virus.

https://www.bmj.com/content/371/bmj.m4037

FDA Meeting briefing – Pfizer vaccine details revealed

December 12, 2020
It DOES NOT prevent infection or spread of the disease. Masks & social distancing are still required. Of the 3410 individuals who got infected during the study, almost half were from the vaccinated group. The vaccine did not prevent infection!

Page 48
Vaccine effectiveness against transmission of SARS-CoV-2
Data are limited to assess the effect of the vaccine against transmission of SARS-CoV-2 from individuals who are infected despite vaccination.

Demonstrated high efficacy against symptomatic COVID-19 may translate to overall prevention of transmission in populations with high enough vaccine uptake, though it is possible that if efficacy against asymptomatic infection were lower than efficacy against symptomatic infection, asymptomatic cases in combination with reduced mask-wearing and social distancing could result in significant continued transmission.

Additional evaluations including data from clinical trials and from vaccine use post-authorization will be needed to assess the effect of the vaccine in preventing virus shedding and transmission, in particular in individuals with asymptomatic infection.

Online Cook book: https://www.fda.gov/media/144245/download?fbclid=IwAR3ujXu-00dEz9Ro_4LnXTWG5Kt2DCoK1SMoZhpcRiNjWqoKrub1xAGGEM4

MHRA Public Assessment Report BNT162b2 RNA

MHRA Medicines & Healthcare products Regulatory Agency
Public Assessment Report online Authorisation for Temporary Supply
COVID-19 mRNA Vaccine BNT162b2 (BNT162b2 RNA)
concentrate for solution for injection
Department of Health and Social Care (DHSC)
Pfizer Limited & BioNTech Manufacturing GmbH

The full report online

Section “Serious adverse events“
Two deaths were reported in participants that received BNT162b2 in Phase 2/3 of study
c4591001; narratives were provided. A participant died 3 days after Dose 1; the provisional
cause of death was atherosclerotic disease. A participant experienced cardiac arrest 60 days after Dose 2 and died 3 days later.

Vaccination card / passport for EU citizens

Covid-19 vaccines: ethical, legal and practical considerations
https://pace.coe.int/en/files/29004/html

7.3.1 ensure that citizens are informed that the vaccination is NOT mandatory and that no one is politically, socially, or otherwise pressured to get themselves vaccinated, if they do not wish to do so themselves

Children’s Health Defence

https://childrenshealthdefense.org
The Defender is experiencing censorship on many social channels.

Do Vaccines Make Us Healthier?

Three groundbreaking studies examined what federal health officials admit they’ve never investigated — whether vaccines improve overall health. The results were “jaw-dropping.”

Everyone, no matter where they stand on the vaccine debate, should want to know the answer to that question.

In the video you’ll learn about three groundbreaking studies that set out to answer this most basic question.

The 3 studies (below) were conducted independently, using different methods — but all three compared the overall health of vaccinated people versus the overall health of the tiny fraction of people in the U.S. who have never been vaccinated.

https://journals.sagepub.com/doi/10.1177/2050312120925344
https://www.mdpi.com/1660-4601/17/22/8674
https://archive.is/PwUrN

New Analysis: Pfizer Vaccine Killed ‘About 40 Times More Elderly Than the Disease Itself Would Have Killed’

A re-analysis of data from the Israeli Health Ministry concluded Pfizer’s COVID vaccine killed “about 40 times more (elderly) people than the disease itself would have killed” during a recent five-week vaccination period, and 260 times more younger people than would have died from the virus.

While in January a group of independent doctors concluded that experimental COVID-19 vaccines are “not safer” than the virus itself, a new analysis of vaccine-related death rates in Israel demonstrates that this may indeed be the case to dramatic levels.

https://childrenshealthdefense.org/defender/israel-pfizer-vaccine-killed-more-elderly-than-covid/

We Need More Details and the Raw Data

Jan 5, 2021
Peter Doshi: Pfizer and Moderna’s ‘95% Effective’ Vaccines — We Need More Details and the Raw Data
Peter Doshi outlines new concerns about the trustworthiness and meaningfulness of the reported efficacy results of Pfizer’s and Moderna’s COVID-19 vaccine trials.

Peter Doshi: Pfizer and Moderna’s ‘95% Effective’ Vaccines — We Need More Details and the Raw Data

Flu Vaccine Facts

A compiled list of resources to help you make informed decisions about the flu vaccine in order to protect you and your family from harm.
For instance, mercury (thimerosal) is a neurotoxin and contained in some flu vaccines. It has been linked to neurodevelopmental disorders and many diseases.

Flu Vaccine Facts

CHD Responds to News of Life-Threatening Reaction to Pfizer COVID Vaccine

Polyethylene glycol (PEG) in COVID mRNA vaccines, could cause severe allergic reactions.

CHD’s concerns about PEG stem from the fact that PEG-specific immune responses can actually reduce the efficacy of vaccines and increase the occurrence of adverse events.

Breaking: CHD Responds to News of Life-Threatening Reaction to Pfizer COVID Vaccine. Will Regulators Take Action?

RFK, Jr. Warned FDA Three Months Ago About Ingredient in Pfizer COVID Vaccine

Moderna, Pfizer/BioNTech and Arcturus Therapeutics COVID vaccines all utilize a never-before-approved messenger RNA (mRNA) technology, an experimental approach designed to turn the body’s cells into viral protein-making factories. This technology involves the use of lipid nanoparticles (LNPs) that encapsulate the mRNA to protect them from degradation and promote cellular uptake.

The LNP formulations in the three COVID-19 mRNA vaccines are “PEGylated,” meaning that the vaccine nanoparticles are coated with a synthetic, non-degradable and increasingly controversial PEG.

RFK Jr. Warned FDA Three Months Ago About Ingredient in Pfizer COVID Vaccine That Likely Caused Life-Threatening Reaction in Two UK Healthcare Workers

RFK, Jr. Urges FDA to Slow Down COVID Vaccine Approval Process

RFK Jr. Urges FDA to Slow Down COVID Vaccine Approval Process

CHD Asks Journal to Retract Study Saying Flu Vaccines Protect Against COVID

The letter details gross errors in “Considering Interim Interventions to Control COVID-19 Associated Morbidity and Mortality — Perspectives,” an original research paper by Mark Christopher Arokiaraj, published Sept. 22 in Frontiers in Public Health.

After reviewing the paper, Kennedy and Hooker concluded that “because of the nature of the error and the faulty conclusions made from the erroneous results, this paper should be retracted as soon as possible.”

CHD Asks Journal to Retract Study Saying Flu Vaccines Protect Against COVID

COVID Vaccine Hesitancy Widespread, Even Among Medical Professionals

Seventy-six percent of the vaccine-hesitant healthcare workers cited the “fast-tracked vaccine development” as a primary reason for their concerns. Typically, vaccines take between eight to 10 years to develop, Dr. Emily Erbelding, an infectious disease expert at National Institute of Allergy and Infectious Diseases, told CNN in an article titled, “The timetable for a coronavirus vaccine is 18 months. Experts say that’s risky.”

COVID Vaccine Hesitancy Widespread, Even Among Medical Professionals

GSK Recycles Its Problematic Adjuvant into Covid-19 Vaccines

GSK and Sanofi Covid-19 vaccine joint effort.
Under this “unprecedented” arrangement, Sanofi will provide the coronavirus antigen while GSK ponies up its trademark AS03 adjuvant system.

Describing AS03’s mechanisms of action in vaccines, GSK researchers have noted that the adjuvant can induce “rapid perturbation” that activates a response called endoplasmic reticulum (ER) stress. An activated ER stress response has been associated with numerous chronic diseases, and severe ER stress also “threatens proper organ function.” Investigators have described an urgent need to study “the consequences of pharmacological interference with ER stress responses.”

AS03 played out quite differently in Europe, where it featured prominently in GSK’s Pandemrix H1N1 “swine flu” vaccine—widely administered in 2009-2010. The U.S. never licensed Pandemrix. In 2010, after Pandemrix received fast-tracked approval from the European Medicines Agency (EMA) under special rules for declared pandemics, an unusually high number of young people—an estimated 1300 in all—developed severe narcolepsy, “all but wreck[ing] normal life.”

Déjà Vu: GSK Recycles Its Problematic Adjuvant Into COVID Vaccines

Pentagon Study: Flu Shot Raises Risk of Coronavirus by 36%

On March 12^th, 2020, Anderson Cooper and Dr. Sanjay Gupta held a global town hall on “Corona Facts and Fears.” During the discussion, Anderson said to the viewing audience, “And, again, if you are concerned about coronavirus, and you haven’t gotten a flu shot…you should get a flu shot.”

Setting safety and efficacy of influenza vaccination aside, is Anderson’s claim that the flu shot will help people fight COVID-19 remotely true? The short answer is no.

In fact, the results of many peer-reviewed, published studies prove that Anderson’s recommendation may have been the worst advice he could have given the public.

Pentagon Study: Flu Shot Raises Risk of Coronavirus by 36% (and Other Supporting Studies)

All of the above CHD articles in 1 PDF Binder

SARS-CoV-2 vaccines in development

No vaccines against coronaviruses have yet been licensed for use in humans.

Traditional vaccine development is a lengthy process, and a development time of 15 years is common (Fig. above). The process begins with exploratory work on vaccine design and evaluation in animal models, which can take years.

This is then followed by a stage in which more formal preclinical experiments are conducted, a process for vaccine production is designed and formal toxicology studies are performed; this stage can also last for several years.

Next, an application for an investigational new drug is filed and phase I clinical trials (testing in fewer than 100 individuals; approximately 2 years) are performed to generate an initial safety profile of the vaccine candidate and to obtain preliminary immunogenicity data.

If the results are promising and funding is available, a vaccine candidate is then moved into phase II clinical trials (testing in a few hundred individuals, also lasting about 2 years) to further investigate immunogenicity and to determine an appropriate dose and optimal vaccine regimens.

If the results of phase II trials are encouraging, the decision might be made to move forward with very costly phase III clinical trials (in thousands of individuals; approximately 2 years) in which efficacy and safety are evaluated.

If the outcome of phase III trials meets the pre-defined end points, a biologics license application is filed with regulatory agencies (for example, the United States Food and Drug Administration (FDA) or the European Medicines Agency).

The licensing process can take another 1–2 years, especially if additional data are requested. Importantly, because it is very expensive, the overall process of vaccine development is slowed by economic risk assessment at every step. Vaccine development progresses through these stages only if the developer is convinced that the data are promising, that the risk of failure is relatively low and that there is (still) a market for the vaccine.

– Text below copied from tweet Jan Bonte, Dutch neurologist –

Although vaccine development is moving forward at an unparalleled speed, there are still many open questions. It is likely that two doses of a vaccine will be required, with booster doses potentially necessary at later time points;

in this case, at least 16 billion doses will be needed to meet the global demand. Many of the vaccines that are described below are being developed by entities that have never brought a vaccine to market, or use technologies that have never resulted in a licensed vaccine.

The upper respiratory tract is thought to be mainly protected by secretory IgA, whereas the lower respiratory tract is thought to be mainly protected by IgG. Vaccines that are administered intramuscularly or intradermally induce mainly IgG, and no secretory IgA.

It is therefore possible that most vaccines currently in development induce disease-preventing or disease-attenuating immunity, but not necessarily sterilising immunity.

For SARS-CoV-2 vaccine candidates, there have so far been no signals of enhanced disease in animal models or in humans; however, such a safety signal would certainly derail the development of a vaccine candidate and would negatively affect vaccine development in general.

– Text above copied from tweet. Jan Bonte, Dutch neurologist –

https://twitter.com/hommel_b/status/1337142457973280774?s=20

https://www.nature.com/articles/s41586-020-2798-3#citeas

https://rdcu.be/cb5jj

Cytokine Storm

A not to difficult read that gives you a good basic understanding about a “cytokine storm” .

In short, cytokine storm involves an immune response that causes collateral damage, which may be greater than the immediate benefit of the immune response.

This year marks 10 years since the first description of a cytokine storm that developed after chimeric antigen receptor (CAR) T-cell therapy1 and 27 years since the term was first used in the literature to describe the engraftment syndrome of acute graft- versus-host disease after allogeneic hematopoietic stem-cell transplantation.2 The term “cytokine release syndrome” was coined to describe a similar syndrome after infusion of muromonab-CD3 (OKT3).3 Cytokine storm and cytokine release syn- drome are life-threatening systemic inflammatory syndromes involving elevated levels of circulating cytokines and immune-cell hyperactivation that can be triggered by various therapies, pathogens, cancers, autoimmune conditions, and monogenic disorders.

Covid-19 –Associated Cytokine Storm (starting at page 14) .. characterized by heterogeneous symptoms ranging from mild fatigue to life-threatening pneumonia, cytokine storm, and multiorgan failure.
Cytokine storm was also reported in patients with SARS and was associated with poor out comes.

https://www.nejm.org/doi/pdf/10.1056/NEJMra2026131?articleTools=true

Epigenetics

WHO vaccination policies will increase diseases in all populations

Judy Wilyman PhD The WHO recommendations for vaccines are a one-size fits all and this fact means that these policies will increase diseases in all populations. They cannot be described as ‘protective health policies’ because they contradict the science of epigenetics; the science showing that individuals are pre-disposed to diseases due to their genetic make-up and the interaction with chemicals in the vaccines.

Videos to Watch Regarding the False Media Presentation of COVID19
May 25, 2020 By Judy Wilyman PhD

More information on Vaccinationsdecisions.net

Dr Bruce Lipton – Stress, Epigenetics and more

Stress is a Chemical, it causes the blood vessels to shut down.
If you understand Epigenetic’s you don’t need the Pharmaceutical Industry.

Dr Bruce Lipton

For those who really want to look beyond the current paradigm of Allopathic medicine / allopathy.

The full interview at LondonReal

Dr Bruce Lipton https://www.brucelipton.com

B.A. in biology from C.W. Post Campus of Long Island University in 1966.
PhD in developmental biology from the University of Virginia in 1971.

1973 to 1982 Taught anatomy at the University of Wisconsin School of Medicine, before joining St. George’s University School of Medicine as a professor of anatomy for three years

Epigenetics fundamentals

Epigenetics is the study of heritable changes in gene expression (active versus inactive genes) that do not involve changes to the underlying DNA sequence — a change in phenotype without a change in genotype — which in turn affects how cells read the genes. Epigenetic change is a regular and natural occurrence but can also be influenced by several factors including age, the environment/lifestyle, and disease state. Epigenetic modifications can manifest as commonly as the manner in which cells terminally differentiate to end up as skin cells, liver cells, brain cells, etc. Or, epigenetic change can have more damaging effects that can result in diseases like cancer. At least three systems including DNA methylation, histone modification and non-coding RNA (ncRNA)-associated gene silencing are currently considered to initiate and sustain epigenetic change.¹ New and ongoing research is continuously uncovering the role of epigenetics in a variety of human disorders and fatal diseases. Epigenetics Fundamentals

Epigenetics explained in simple terms (3 minutes)

Dr. Eric Berg, DC

Young doctor explains why he’s against forced COVID-19 vaccine

A COVID-19 vaccine should not be mandatory, and getting people to take it “serves certain special interests,” a young medical doctor told LifeSiteNews.

“I have no doubt about it,” Dr. Leland Stillman said when LifeSite’s video reporter Jim Hale asked him if the push for the vaccine had, in many ways, to do with money. Hale spoke with Stillman at the “March Against Mandates” in Richmond, Virginia, last week.

Full story https://www.lifesitenews.com/news/young-doctor-explains-why-hes-against-forced-covid-19-vaccine?utm_source=YT_Stillman

National Childhood Vaccine Injury Act of 1986 – The Legislation that Changed Everything

NCVIA: The Legislation that Changed Everything—Conflicts of Interest Undermine Children’s Health: Part II

eBook Conflicts of Interest Undermine Children’s Health

SAGE conflicts of interest

WHO Strategic Advisory Group of Experts (SAGE)

Dr Zoë Harcombe Ph.D.

November 9, 2020

Executive summary

* As late as March 11th, 2020, the UK government and medical officers issued practical and minimally disruptive advice to combat the spread of the novel coronavirus.

* On March 16th, the now infamous Neil Ferguson/Imperial College paper was published predicting over 500,000 deaths in the UK and 2.2 million in the US if suppression measures were not introduced.

* Stricter measures were announced on the day that paper was published, and the first UK lockdown was announced a week later, on March 23rd. US states variously followed suit.

* The committee that has been advising the government throughout this period is called the Scientific Advisory Group for Emergencies (SAGE). Ferguson was a member of this committee until he resigned in May for having broken lockdown rules.

* This week’s note examines the key influencers on SAGE and their conflicts of interest:

– Organisations invested in vaccines make money from vaccines. People who acquire natural immunity have less/no need for a vaccine. If people are locked in their homes, they have less chance of acquiring natural immunity.

– Twelve out of 20 key influencers work for/have received funding from organisations involved in the Covid-19 vaccine.

– There are four times more modellers/statisticians and experts in behaviour manipulation on the committee than there are virologists. There are no immunologists.

* It doesn’t matter if a drug is good or bad. It matters that those who have a financial interest in that drug are conflicted if they give advice that protects the financial interest in that drug.

Online https://www.zoeharcombe.com/2020/11/sage-conflicts-of-interest/

MD Stanley Plotkin speaks under oath about vaccine ingredients.

Dr. Stanley Plotkin considered one of the leading experts on vaccines and vaccinations.

In the 1960s, he played a critical role in the development of the rubella vaccine and several manufacturers ask him for his advice.

And if you have 9 hours to spare the full version:
Aborted fetal tissues are used in vaccines. Vaccines have been experimentally tested on orphans and on mental handicapped children. Experimental tests on babies from mothers in prisons. Experimental tests on 1 million people in then colonial Belgian Congo. Shocking video.

Dr. Carrie Madej – My alarm call to the world 

Internal Medicine Specialist in McDonough, GA Graduated from Kansas City Univ Of Medicine Bioscience College Of Osteopathic Medicine medical school in 2001. Affiliated with medical facilities Piedmont Fayette Hospital and Southern Regional Medical Center. 

RNA vaccines, classes of vaccine that has never been approved for human use in the U.S. and involve injecting foreign genetic material into the human body. Notably, it is this very class of vaccine, now being produced by DARPA-partnered companies, that billionaire and global health “philanthropist” Bill Gates recently asserted has him “most excited” relative to other Covid-19 vaccine candidates. Yet, key aspects regarding these vaccines and other DARPA “healthcare” initiatives have been left out of these recent positive reports.

Watch this highly informative video by physician Dr. Carrie Madej, explaining the 3 major components of the Moderna vaccine and the implications.
If we allow the mandatory vaccination rhetoric to proceed , humans will no longer be human.  Dr. Madej does an outstanding job going into greater detail. Remember, the function of RNA is to repair and re-write the DNA.

Another great article on this subject: 

FDA Nears Approval of Injectable Biochip Implants for COVID Detection

The Department of Defense, and the Bill and Melinda Gates Foundation, have partnered with a Silicon Valley company, Profusa, to implement a technology which could control our minds and bodies. What may seem like science fiction, is in fact happening in real-time.

A permanent chip made of an advanced material called hydrogel irreversibly ties humans to the Internet “cloud.” The chip, about the size of a grain of rice, provides feedback to a database on changes in body chemistry and other biometrics. The company says technology will be used to detect COVID in the general population, before symptoms show.

The latest revised CDC overall survival rate for the COVID virus is 99.8%, versus 99.9% for the common flu. Nevertheless, nearly 150 days after governments proclaimed that 15 days of “lockdowns” and social distancing would be necessary to “flatten the curve” so that hospitals would not be overwhelmed, US governors still exert emergency powers based on the announcement of “new cases.”

Full article: https://steemit.com/covid/@munkle/permanent-injectable-biochip-covid-sensors-near-fda-approval Reader view backup:

Robert F Kennedy Jr. at Londonreal.tv

My fight agains mandatory vaccinations, big pharma and Dr. Fauci

Children’s Health Defense; Measles Vaccination and Autism

In a surprisingly candid systematic review of the autoantibody literature just published in Research in Autism Spectrum Disorders, authors from Harvard and other American universities cite long-standing evidence that viral vaccines—and explicitly the MMR—are one of the culprits capable of knocking the immune system off its game.

Full article https://childrenshealthdefense.org/news/measles-vaccination-and-autism-the-inexcusable-suppression-of-a-long-documented-link/

Instagram video July 7, 2020 Robert f Kennedy; discussion with Dr. Andy Lakefied

Influenza vaccination and respiratory virus interference

Vaccinated individuals may be at increased risk for other respiratory viruses because they do not receive the non-specific immunity associated with natural infection.

Additionally, the laboratory data in our study showed increased odds of coronavirus and human metapneumovirus in individuals receiving influenza vaccination. 

The overall results of the study showed little to no evidence supporting the association of virus interference and influenza vaccination. 

https://europepmc.org/article/MED/31607599

Does the Flu Shot Increase COVID-19 Risk (YES!) 

Dr. Michael Murray  This may be the most important newsletter I have written to date. Here are a few quick answers to the questions I will cover in case you aren’t interested in the whole story:

• Does the flu shot increase the risk for coronavirus infection? YES!
• Could a new flu vaccine be partly responsible for the COVID-19 mortality rate in Italy?  YES!
• Is the rush to a vaccine the best solution? No, it could bring catastrophic results.
• How does the SARS-CoV-2 infect and are protease enzyme supplements the key to creating our own endogenous antiviral protease inhibitors? Yes, I believe so!
• Are there certain medications like blood pressure drugs and proton pump inhibitors that increase risk for infection and mortality?  YES
• Is it chloroquine or is it zinc that is working as a possible aid in treating COVID-19? A strong case can be made for zinc!
• Can plant polyphenols and flavonoids act to increase the antiviral effects of zinc? YES! And they possess other benefits too!

https://doctormurray.com/does-the-flu-shot-increase-covid-19-risk

Flu shots contain suspect ingredients, carcinogen formaldehyde, mercury in the form of thimerosal.

“Mercury is one of the most poisonous substances known to mankind,” Dr. Brownstein tells Newsmax Health. “It is a potent neurotoxin and is associated with a host of neurological and immune system problems. Mercury should never be injected into any living human being.”

Thimerosal, a preservative found in many flu shots, is 50 percent mercury. It’s different, and much more harmful, than the type of mercury found in fish. While the FDA warns against eating more than two servings of fish weekly because of the danger of mercury, it allows this more toxic form to be added to flu shots (and other vaccines). 

“There’s no doubt that the flu vaccine can lead to Alzheimer’s, because many flu shots are preserved with mercury and it’s a known brain toxin,” says Dr. Brownstein. “You give enough brain toxins and people are going to develop memory issues.”

“Those promoting flu shots promise they’ll cut your risk of getting flu by more than 50 percent, but that’s simply not true. When you dissect the studies, you’ll find the FluLaval vaccine is 97 percent ineffective.”

Full article https://www.newsmax.com/Health/Headline/flu-shots-vaccine-thimerosal/2014/11/20/id/608614/

An aluminium adjuvant in a vaccine is an acute exposure to aluminium

Simply by looking at just one dose of a vaccine given at 8 weeks of age it is abundantly clear that science does not support this contention, as espoused regularly by many infant paediatricians. In fact, just a single dose of Infanrix Hexa vaccine represents a severe acute exposure to systemically available aluminium.
A single dose of this vaccine is equivalent to the exposure to aluminium that an infant would receive from 150 days breast-feeding. It is equivalent to 25 times the daily dose of aluminium received from the most contaminated of infant formulas. It is pertinent to emphasise that an infant would receive a further two doses of this vaccine during the aforementioned 150 day period. It is also highly relevant that other aluminium adjuvanted vaccines, for example Prevenar 13 (https://www.medicines.org.uk/emc/product/453/smpc) and Men B (https://www.medicines.org.uk/emc/product/5168/smpc) are also part of the infant vaccine schedule for this same period.
In the United Kingdom it is not uncommon for an infant to receive all three of these aluminium adjuvanted vaccines on the same day. A combined daily exposure of 1.445 mg of aluminium (according to the manufacturer’s data), equivalent to 260 days exposure to aluminium through breast feeding. Exposure to aluminium through a vaccine is, in comparison to diet, an acute exposure and an infant’s physiology will respond differently to exposure to a high concentration of aluminium over a very short time period. The latter, acute versus chronic exposure, while not yet being taken into account in infant vaccination programmes, must now be considered to help to ensure that future vaccination schedules are safe. Currently the EMA and the FDA limit the aluminium content of a vaccine to 1.25 mg (See for example, https://www.ecfr.gov/cgi-bin/text-idx?SID=832c22988b6c802fe810e16ea34ace1a&mc=true&node=se21.7.610_115&rgn=div8). This limit is based upon the aluminium adjuvant’s efficacy in inducing antibody titres.
Perhaps now is the time to revise this limit based upon additional factors of vaccine safety.

https://www.sciencedirect.com/science/article/pii/S0946672X19304201?via%3Dihub

Past vaccine disasters show why rushing would be ‘colossally stupid’

CNN Health’s Jamie Gumbrecht contributed to this story
Vaccine experts are warning the federal government against rushing out a coronavirus vaccine before testing has shown it’s both safe and effective. Decades of history show why they’re right.

https://edition.cnn.com/2020/09/01/health/eua-coronavirus-vaccine-history/index.html Reader view backup for download:

DNA vs. RNA – 5 Key Differences and Comparison

Deoxyribonucleic acid (DNA) and Ribonucleic acid (RNA) are perhaps the most important molecules in cell biology, responsible for the storage and reading of genetic information that underpins all life. They are both linear polymers, consisting of sugars, phosphates and bases, but there are some key differences which separate the two.

BOOK: VACCINATION proved Useless & Dangerous.

VACCINATION proved Useless & Dangerous from 45yrs of registration statistics by Alfred R. Wallace, 1889

https://archive.org/details/b2136140x/mode/2up?view=theater